Publications by authors named "K Furu"
Article Synopsis
- The study investigates how using antidepressants during pregnancy impacts various birth outcomes, including stillbirth and preterm delivery.
- It analyzed data from over 2.5 million births across the UK and Scandinavia, discovering that 4.8% of deliveries involved mothers who used antidepressants.
- Results indicate a slight increase in risks for negative outcomes like stillbirth and low Apgar scores linked to maternal antidepressant use, but these risks remained low overall and might be influenced by underlying mental health conditions.
Article Synopsis
- Many pregnant women stop taking important medications called SSRIs and SNRIs, which help with depression and anxiety, and this affects their health after having a baby.
- Researchers studied nearly 28,000 pregnant women in Sweden to see how stopping these medications impacted their mental health and time off work after childbirth.
- They found that about half of the women stopped using these medications, and those who did were often younger, less educated, and more likely to have smoked during pregnancy.
Objective: Little is known about thyroid cancer survivors' risk of chronic conditions. We, therefore, investigated the prevalence of drugs used for chronic conditions among thyroid cancer patients using population-wide register data.
Methods: We linked data from the Cancer Registry of Norway to the Norwegian Prescription Database and other databases for a study population of 3.
Article Synopsis
- There are significant safety concerns about using smoking cessation medications during pregnancy, particularly regarding the risk of congenital malformations, leading to recommendations against certain drugs like varenicline and bupropion, and caution with nicotine replacement therapy (NRT).
- The study aimed to assess how many pregnant individuals were prescribed smoking cessation medications in New South Wales, New Zealand, Norway, and Sweden from 2015 to 2020, particularly during the first trimester.
- Out of over 1.7 million pregnancies studied, a small percentage (up to 11.39%) of pregnant women who smoked used pharmacotherapies, with the highest usage rates for NRT and varenicline in certain regions.*